Gastric Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Gastric Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-06-04Clinical Trial Update: Adujvant CT+CRT vs Adujvant CT After D2 Resection for Locally Advanced Proximal Gastric Adenocarcinoma [Phase 3]
Phase 3 trial comparing adjuvant chemotherapy plus chemoradiation versus adjuvant chemotherapy after D2 resection in locally advanced proxim…
-
CLINICAL_TRIALS trial_result · 2019-05-20Clinical Trial Update: Single-arm Study of Selumetinib in Combination With Docetaxel, in Advanced Gastric Adenocarcinoma Patients With Low/High MEK Signature, RAS Mutation or RAS Amplification as a Second-line Chemotherapy [Phase 2]
Phase 2 single-arm trial evaluating selumetinib with docetaxel in advanced gastric adenocarcinoma patients with MEK signature or RAS alterat…
-
CLINICAL_TRIALS trial_result · 2019-05-10Clinical Trial Update: Apatinib Combined With POF for Second-line Treatment of Gastric Adenocarcinoma [Phase 2]
Phase 2 trial evaluating apatinib combined with polypeptide- or POF for second-line treatment in gastric adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: MetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating metronomic capecitabine and docetaxel as second-line chemotherapy for advanced gastric/gastroesophageal ju…
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers [Phase 2]
Phase 2 trial assessing CRS-207 with pembrolizumab in gastric, gastroesophageal junction, and esophageal adenocarcinomas; study terminated w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: A Study of Ramucirumab in Participants With Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial update for ramucirumab in metastatic gastric and gastroesophageal junction adenocarcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer [Phase 2]
Phase 2 trial of ramucirumab with paclitaxel in gastric cancer completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-20Clinical Trial Update: A Study of Pembrolizumab (MK-3475) Versus Paclitaxel for Participants With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma That Progressed After Therapy With Platinum and Fluoropyrimidine (MK-3475-061/KEYNOTE-061) [Phase 3]
Phase 3 trial comparing pembrolizumab to paclitaxel in advanced gastric/GEJ adenocarcinoma after platinum/fluoropyrimidine showed completed …
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Study of the Combination of Apatinib and POF [Phase 2]
Phase 2 clinical trial update on the combination of Apatinib and POF for gastric adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2018-10-01Clinical Trial Update: Compare Neoadjuvant Chemotherapy of DOS Versus SOX in Locally Advanced Gastric Adenocarcinoma. [Phase 2, Phase 3]
Clinical trial comparing neoadjuvant DOS versus SOX in locally advanced gastric adenocarcinoma (Phase 2/3). Status unknown.
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer [Phase 3]
Phase 3 trial of ramucirumab with capecitabine and cisplatin in metastatic gastric/GEJ adenocarcinoma completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma [Phase 2]
Phase II trial of cabazitaxel for refractory metastatic gastric adenocarcinoma and gastroesophageal adenocarcinoma completed; results were p…
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: mDCF + Avelumab in Resectable Esophago-gastric Adenocarcinoma (EGA) [Phase 2]
Phase 2 trial update evaluating the combination of modified DCF chemotherapy (docetaxel, cisplatin, and 5-fluorouracil) with Avelumab in res…
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Resilience and Exercise in Advanced Cancer Treatment [NA]
The clinical trial evaluating resilience and exercise in advanced cancer has completed, involving pancreatic adenocarcinoma, gastric adenoca…
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 clinical trial evaluating pralatrexate and oxaliplatin in unresectable or metastatic esophageal, stomach, or gastroesophageal juncti…
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction [Phase 2]
Phase 2 trial results evaluating irinotecan in combination with cisplatin for patients undergoing surgery for locally advanced gastric or ga…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors [Phase 2]
Phase 2 trial of AMG 337 in MET-amplified gastric and esophageal adenocarcinoma and other solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Serum and Peritoneal CEA and CA 19-9 for Gastric Adenocarcinoma
This completed clinical trial evaluated serum and peritoneal levels of CEA and CA 19-9 as potential biomarkers in patients with gastric aden…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Elimination of Peritoneal Tumor Cells With Extensive Peritoneal Lavage During Surgery in Patients With Gastric Cancer [NA]
A clinical trial evaluating extensive peritoneal lavage during gastric cancer surgery to eliminate peritoneal tumor cells has been terminate…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: MLN0264 in Previously Treated Asian Participants With Advanced Gastrointestinal Carcinoma or Metastatic or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Guanylyl Cyclase C [Phase 1]
Phase 1 trial update of MLN0264 in previously treated Asian patients with advanced gastrointestinal carcinoma, including gastric and gastroe…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: A Clinical Trial of Apatinib Plus Docetaxel in Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma [Phase 1]
Phase 1 clinical trial evaluating the combination of apatinib and docetaxel in locally advanced or metastatic gastric or GEJ adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Covered Versus Uncovered Self-expandable Metallic Stents for Malignant Gastric Outlet Obstruction [Phase 3]
A Phase 3 trial comparing covered versus uncovered self-expandable metallic stents for malignant gastric outlet obstruction due to gastric a…
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: Trastuzumab Based Therapy in HER2 Positive AGC
A trial evaluating trastuzumab-based therapy for HER2-positive gastric adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma Study [Phase 2]
Phase 2 gastric adenocarcinoma study evaluating whether genetic polymorphisms can predict treatment efficacy and toxicity; the trial has bee…
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Docetaxel+Oxali+/-Cetux Met Gastric/GEJ [Phase 2]
Phase 2 trial assessed docetaxel plus oxaliplatin, with or without cetuximab, in metastatic gastric/GEJ adenocarcinoma; results were posted …